Assessment of L-lactatemia as a predictor of respiratory disease recognition and severity in feedlot steers.

The bovine respiratory disease complex (BRD) is a major health issue in feedlot cattle and one of the primary reasons for antimicrobial use in the North American feedlot industry. The purpose of the present study was to assess blood L-lactate levels of feedlot steers at high risk of developing BRD during the early feeding period. Blood samples were obtained at initial processing and again after BRD confirmation (using bronchial lavage or thoracic ultrasound exam). The study involved 232 recently weaned steers received at a single research feedlot that were processed without metaphylactic antimicrobial treatment. Blood samples were obtained for determination of L-lactatemia and temperament scores (very quiet or stoic [score 1], average [score 2] and very excited [score 3]) were systematically assigned at initial processing. A subsample of calves that were later confirmed as cases of BRD were sampled at first pull (day 0), and at subsequent observation points on days 3, 6, 9 and 15 following initial BRD diagnosis for blood lactate determination as a potential indicator of subsequent death. The clinical BRD cumulative incidence in the cohort was 38% (87/232). Temperament was associated with the probability of becoming a BRD case during the early feeding period. Stoic or very excited calves showed 2.2 times higher odds (95%CI: 1.3, 3.8) of becoming BRD cases compared to calves with average temperament. The impact of L-lactatemia differed by temperament strata. In calves with a temperament score of 2 (average temperament) every 1-log unit increase of lactatemia at processing resulted in 1.9 times higher odds (95% CI: 1.2, 3.1) of becoming a BRD case; this relationship was not significant in calves with a score of either 1 or 3. Twenty-nine confirmed BRD cases were studied for the dynamic lactate assessment analysis. L-lactate at first pull was not significantly different between survivors (median 3.3mmol/L; range 0.8-7.8mmol/L) and non-survivors (median 2.7mmol/L; range: 1.6-5.4mmol/L) steers. However, the dynamic assessment of L-lactatemia was associated with the hazard of death using Cox proportional hazard survival analysis. A 1-log increase of lactatemia increased the hazard of dying prior to the next observation by a factor of 36.5 (95% CI: 3.5-381.6). For calves showing a normal temperament score (i.e. temperament score of 2), a misclassification cost term analysis was conducted to identify potential L-lactate test thresholds for identifying future BRD steers. When planned test usage was for informing decision of administering or not a metaphylactic treatment at processing, experts agreed that false-negative (not treating a calf that would have benefit from treatment) to false-positive (wrongfully treating a calf that would have remained healthy) health costs ratio ranged from 8:1 to 20:1. In this situation, a threshold of 5mmol/L would have best informed treatment decision. When using L-lactate for informing the type of antimicrobial used at processing, false-negative to false-positive health costs ratio ranging from 1:1 to 3:1 could be expected and, again, a L-lactate threshold of 5.0mmol/L would have minimized the costs associated with calves' misclassification and could be used to identify calves that would benefit from a more efficient metaphylactic treatment. This study provides an interesting perspective on the potential application of chute-side markers or diagnostic tests to stratify the risk of future pull for BRD in cattle during processing in order to adapt antimicrobial treatments accordingly.

Relationship between serum phosphorus levels and various outcome measures in adult hemodialysis patients.

OBJECTIVE: To compare three different mean serum phosphorus ranges on outcomes related to the control and treatment of hyperparathyroidism (HPTH), to nutritional status, and to quality of life (QOL) in adult hemodialysis (HD) patients. DESIGN: Patients were grouped based on the mean of five monthly phosphorus levels achieved during the study period. Group 1 included patients whose mean phosphorus levels over the period was <6.0 mg/dL (n = 24); group 2 averaged between 6.0 and 6.9 mg/dL (n = 14); and group 3 averaged >7.0 mg/dL (n = 16). Descriptive comparisons were made between phosphorus groups. PATIENTS: Fifty-four stable, adult HD patients participated voluntarily. MAIN OUTCOME MEASURES: Intact-parathyroid hormone (iPTH), calcium x phosphorus product (Ca x P), and change in iPTH, albumin (alb), total protein (tpro), weight (wt) and body mass index (BMI), and scores on a QOL survey. Baseline physical and lab characteristics. RESULTS: No difference was found between phosphorus levels of <6.0 mg/dL and levels of 6.0 to 6.9 mg/dL in iPTH, Ca x P levels allowing safe calcitriol therapy, nor response to calcitriol treatment. Patients with phosphorus levels >7.0 mg/dL had midstudy iPTH greater than phosphorus levels <6.0 mg/dL. Otherwise the three groups did not differ significantly in iPTH levels. Phosphorus levels 6.0 to 6.9 mg/dL was associated with lowest wt and BMI, but alb and tpro did not differ between the phosphorus groups. Phosphorus levels of >7.0 was associated with highest creatinine levels and youngest age. Subjects in the phosphorus levels of <6.0 mg/dL gp were more likely than the 6.0 to 6.9 mg/dL gp to describe their diet as sufficient and, at baseline, were more likely to relate diet to QOL. CONCLUSION: Comparison of three levels of serum phosphorus on indicators of outcome in the control and treatment of secondary hyperparathyroidism showed no significant difference in outcome between phosphorus levels of <6.0 mg/dL and phosphorus levels 6.0 to 6.9 mg/dL. However, the data suggests that phosphorus levels of >7.0 mg/dL may relate to significantly higher iPTH and unacceptable Ca x P levels. There were no differences between the groups, suggesting less favorable outcome at any of the three phosphorus levels regarding nutritional status or QOL in this small group of stable, adult HD patients.

Effects of verapamil and converting enzyme inhibition on bilateral renal function of two-kidney, one-clip hypertensive rats.

Experiments were conducted in two-kidney, one-clip renal vascular hypertensive rats (GHR) to assess the responses of each kidney to acute treatment with the antihypertensive calcium channel blocking agent verapamil in the presence and in the absence of converting enzyme inhibitor (CEI). One group of GHR (0.2 mm inner diam. clip 3 weeks before study) were examined during a control period, and during a second period of infusion of verapamil (600 micrograms h-1 kg-1). A second group of GHR were examined during a control period, during CEI (teprotide, 3 mg h-1 kg-1) infusion and during a third period of verapamil (600 micrograms h-1 kg-1) infusion superimposed on CEI infusion. Although systemic blood pressure (BP) decreased from 175 +/- 4 to 149 +/- 5 mmHg (mean +/- SEM) in response to verapamil alone, renal blood flow for non-clipped kidneys increased from 5.9 +/- 0.4 to 6.5 +/- 0.3 ml/min, indicating a 30% reduction of renal vascular resistance (P values less than or equal to 0.01; n = 9). Glomerular filtration rate (GFR) for non-clipped kidneys (n = 24) increased from 0.91 +/- 0.09 to 1.47 +/- 0.14 ml/min and filtration fraction increased from 0.32 +/- 0.04 to 0.47 +/- 0.03 (P values less than or equal to 0.05). Urine flow rate and absolute and fractional sodium excretion for non-clipped kidneys increased. GFR for clipped kidneys decreased during verapamil. Treatment with CEI alone resulted in nearly identical responses of BP and function of the non-clipped kidney, except filtration fraction was unchanged. The addition of verapamil to ongoing converting enzyme blockade tended to augment the increased GFR of the non-clipped kidney. Plasma renin activity (PRA) increased from 30 +/- 3 to 59 +/- 7 ng of angiotensin (ANG) I h-1 ml-1 with verapamil alone, a significantly larger increment than the increase of PRA from 27 +/- 5 to 39 +/- 9 ng of ANG I h-1 ml-1 in GHR subjected to comparable blood pressure reduction by mechanical aortic constriction. Verapamil resulted in many similar effects on renal function to those observed during blockade of converting enzyme. The increased filtration fraction observed in response to verapamil may be the result of vasodilatation of the afferent arteriole or of an increase in the glomerular ultrafiltration coefficient.

Comparison of electron microscopy with three commercial tests for the detection of rotavirus in animal feces.

Three commercial test kits were evaluated to detect the presence of rotavirus antigens in bovine, porcine, and turkey feces. Two of the assays, Rotalex (Medical Technology Corporation, Somerset, NJ) and Virogen-Rotatest (Wampole Labs, Cranbury, NJ) are latex agglutination tests (LA), while the third, Pathfinder (Kallestad, Austin, TX) is an enzyme immunoassay. The clinical usefulness of these assays was elevated by comparing their results with those of direct electron microscopy (EM). A total of 135, 92, and 211 samples of animal feces were tested by Rotalex, Virogen, and Pathfinder, respectively. All samples were examined by EM as a reference procedure. The overall agreement of the three commercial assays with EM was 53%, 66%, and 83% for Rotalex, Virogen, and Pathfinder, respectively. Based on these results, we consider Pathfinder as an attractive alternative to EM for the detection of rotavirus in animals. Of the two LA tests, Virogen was found to be a little more sensitive and specific.

Effects of angiotensin inhibition and renal denervation in two-kidney, one clip hypertensive rats.

Neural and angiotensin-mediated influences that alter hemodynamic and excretory behavior of the nonclipped kidney of two-kidney, one clip hypertensive rats were assessed by sequential acute surgical denervation of the nonclipped kidney and intravenous infusion of converting enzyme inhibitor (SQ 20881), 3 mg/kg X hr. Normal and two-kidney, one clip hypertensive rats (0.2-mm silver clip on the right renal artery 3-4 weeks before study) were prepared to allow study of each kidney. Mean arterial blood pressure of two-kidney, one clip hypertensive rats fell significantly from control values of 149 +/- 6 to 135 +/- 6 mm Hg after denervation of the nonclipped kidney. Despite this decrease in arterial pressure, the nonclipped kidney exhibited significant increases in glomerular filtration rate (from 1.00 +/- 0.08 to 1.24 +/- 0.08 ml/min), sodium excretion (from 88 +/- 39 to 777 +/- 207 nEq/min), fractional sodium excretion (from 0.06 +/- 0.02 to 0.54 +/- 0.14%), and urine flow rate (from 3.7 +/- 0.5 to 8.2 +/- 1.1 microliter/min). A significant decrease in glomerular filtration rate (from 1.12 +/- 0.07 to 0.85 +/- 0.08 ml/min) with no change in excretory function was observed for the clipped kidney following denervation of the nonclipped kidney. Intravenous addition of converting enzyme inhibitor significantly increased renal blood flow (from 7.0 +/- 1.3 to 10.6 +/- 1.5 ml/min) and sodium excretion (from 777 +/- 207 to 1384 +/- 425 nEq/min) for the nonclipped kidney; blood pressure decreased from 135 +/- 6 to 123 +/- 4 mm Hg, and renal vascular resistance decreased significantly (from 22 +/- 3 to 13 +/- 2 mm Hg X min/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Antibodies against canine parvovirus in wolves of Minnesota: a serologic study from 1975 through 1985.

Serum samples (n = 137) from 47 wild wolves (Canis lupus; 21 pups and 26 adults) were evaluated from 1975 to 1985 for antibodies against canine parvovirus, using the hemagglutination inhibition (HI) test. In addition, several blood samples (n = 35) from 14 of these wolves (6 pups and 8 adults) were evaluated simultaneously for erythrocyte and leukocyte counts, and for hemoglobin and blood urea nitrogen concentrations. Sixty-nine (50%) of the serum samples (35 wolves) had HI titers of greater than or equal to 256, whereas 68 (50%) of the samples (16 wolves) had HI titers of less than or equal to 128. Significant differences in the geometric mean titers were not found between pups and adults or between males and females. Of the 47 wolves evaluated, 12 (25%) developed a greater than or equal to fourfold increase in antibody titers during the 11-year period, with 2 wolves developing serologic conversions in 1976. The data indicate that canine parvovirus may have begun infecting wolves before or at the same time that it began infecting the dog population in the United States.

Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system.

To determine the effect of activation of the reticuloendothelial system on the localization of immune complexes in the kidney, a model of passive serum sickness nephritis in the mouse was used, with activation of the reticuloendothelial system with Corynebacterium parvum. Groups of mice, control and C. parvum-treated animals, were injected with BSA-125I-anti-BSA complexes containing 3 mg 125I-anti-BSA. Blood was obtained at 5 min, at 3 h, and at 12 h, when the animals were killed. Blood concentrations of BSA-125I-anti-BSA complexes were reduced in C. parvum-treated animals compared with controls. This appeared to be mediated by two effects, increased uptake of complexes in the liver and spleen, and enhanced degradation of immune complexes as measured by TCA-soluble radioactivity. In vitro studies using cultures of peritoneal macrophages also showed enhanced uptake of immune complexes. The amount of immune complexes deposited in the glomeruli of C. parvum-treated animals was reduced as determined by quantitation of radiolabeled material bound to isolated gomeruli and by immunofluorescence techniques. The results of the study emphasize the role of the reticuloendothelial system in the modulation of immune complex localization in the kidney and suggest a potential use of stimulants of the reticuloendothelial system in the therapy of immune complex nephritis.

[Leucosis diagnosis in cattle using the Sudan black B staining method on granulocytes and monocytes]. / Vyuzití barvicí metody sudanovou cerní B u granulocytû a monocytû skotu pro diagnostiku leukóz.

In the peripheral blood of healthy cattle and cattle suffering from leucosis a positive reaction with Sudan black B was found in neutrophilic and eosinophilic granulocytes: in healthy cattle at an intensity from ++ to ++++, and in cattle suffering from leucosis it was somewhat slighter (++ to +++). This finding can, to a certain extent, help in the distinguishing of reactive lymphocytosis from the leucosis of cattle. Compared with granulocytes the reaction of monocytes is markedly weaker: in healthy cattle at an intensity from 0 to (++), and in diseased cattle from 0 to (+++). In the bone marrow there is a significantly weaker reaction to Sudan black B in the group of large cells (neutrophilic and eosinophilic promyelocytes and myelocytes); in the group of healthy and diseases cattle the reaction is weaker than in neutrophilic and eosinophilic granulocytes of the peripheral blood. The reaction obtained with Sudan black B for lipids can be used as an aid for the distinguishing of cells of the myeloid, monocytic, and lymphoid order of peripheral blood and bone marrow in cattle leucosis.

[Nonspecific esterase and naphthol-AS-D-chloroacetate esterase in monocytoid and myeloid cells of healthy cattle and cattle suffering from leukosis]. / Nespecifická esteráza a naftol-AS-D-chloracetátesteráza u monocytoidních a myeloidních bunék zdravého a leukózního skotu.

The reaction to non-specific esterase can be used for the identification of the monocytoid cells of the periphery. A negative reaction is exhibited by neutrophile and eosinophile leucocytes and erythrocytes. Varying results are obtained from lymphocytes, rendering it impossible to use this method in the group of lymphoid cells of the periphery or marrow. In the group of large marrow cells (promonocytes), non-specific esterase gave a very strong reaction; this applies both to the marrow of healthy cattle and cattle suffering from leucosis. For the time being, efforts to use this reaction for the solution of the problem of the differentiation of monocytoid cells and cells of similar size in the myeloid series of the bone marrow have not been successful. In neutrophile leucocytes of the periphery, naphtol-AS-D-chloroacetate esterase gives a less intensive reaction than in humans. For this reason, it is less suitable for the differentiation of these cells. Other cell types (eosinophile leucocytes, monocytes, lymphocytes, erythrocytes as well as their bone-marrow stages) give a negative reaction. In the group of large marrow cells of the myeloid series (promyelocytes and neutrophile myelocytes), naphtol-AS-D-chloracetate esterase shows a more intensive reaction in healthy cattle, as compared with cattle suffering from leucosis.

[Determination of glycogen in leukocytes of healthy and leukemic cattle]. / Prükaz glykogenu v leukocytech skotu zdravého a leukózního

In leukemic cows the percentage of leucocytes and lymphoid cells of the peripheral blood and marrow, with intensely stained violet glycogen granules in the plasma, which nevertheless exceptionally appear even in the leucocytes and lymphocytes of healthy cows, is significantly higher. Lymphocytes with a negative PAS reaction are found in both healthy and leukemic cows. PAS reaction can therefore be used as an auxiliary method for differentiating leukemic lymphocytes in a complex of further cytochemical reactions. In neutrophilous peripheral blood leucocytes of healthy and leucotic cattle the PAS reaction attained the values of ++ to +++. In the marrow of both groups an attenuated reaction was recorded in the myelocytes and promyelocytes (0 to +). Eosinophilous leucocytes and their developmental stages yielded negative PAS reaction. Monocytes showed a weak reaction in the periphery of healthy cattle whereas in the leucotic cattle the reaction was somewhat stronger, PAS reaction of the erythrocyte and thrombocyte bone marrow series was negative.